TriSalus Life Sciences, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↑+47.4% +$11M
$35M
Current Assets↑+56.0% +$12M
$32M
Cash & Equivalents↑+139.8% +$12M
$20M
Receivables↑+28.9% +$1M
$7M
Inventory↓-24.0% -$971K
$3M
Net PPE
$2M
Intangibles
$1M
Total Liabilities↑+38.8% +$19M
$69M
Current Liabilities↑+12.4% +$1M
$11M
Long-Term Debt↑+49.6% +$11M
$33M
Stockholders Equity↓-30.8% -$8M
$-34M
Retained Earnings↓-18.3% -$51M
$-331M
Operating Lease ROU Asset↓-28.8% -$349K
$861K
Operating Lease Liability↑+0.2% +$3K
$1M
Finance Lease ROU Asset↓-38.3% -$49K
$79K
Inventory Raw Materials↓-3.7% -$49K
$1M
Inventory Finished Goods↓-30.3% -$823K
$2M